Mar 26, 2025
Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
Mar 21, 2025
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
Mar 13, 2025
NTx Establishes Scientific Advisory Board with Distinguished Leaders in Oncology
Mar 11, 2025
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)
Feb 25, 2025
Humanetics Corporation Chief Medical Officer Is Featured Guest at U.S. Industry, National Security, and Healthcare Forum
Feb 24, 2025
Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing
Feb 18, 2025
GeminiBio Appoints Mike Stella to Board
Feb 11, 2025
T-Mobile, RAM, Liquid Death Awarded Most Engaging Super Bowl LIX Ads
Jan 29, 2025
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
Jan 20, 2025
Kincell Bio Welcomes Industry Veteran Mark R. Bamforth as Chief Executive Officer to Drive Business Growth
Jan 13, 2025
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
Jan 07, 2025
BWXT Enters Agreement to Acquire Kinectrics, a Leading Service Provider to the Global Nuclear Market
Jan 03, 2025
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia
Dec 12, 2024
PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
Dec 10, 2024
Humanetics Secures Additional Funding to Advance Development of Its Drug to Prevent Radiation Injury
Dec 05, 2024
Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
Dec 04, 2024
Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors
Dec 03, 2024
Mirion to Detail Financial Targets and Long-term Strategy at Today’s Investor Day
Dec 03, 2024
Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE
Nov 25, 2024
Antiplatelet Market Analysis Report 2024, Featuring Profiles of AstraZeneca, Sanofi, Daiichi Sankyo, Bayer, Torrent Pharmaceuticals, Lupin, Cipla, Baxter, Takeda and Glenmark Pharmaceuticals - ResearchAndMarkets.com